Back to search

Article

Development and characterization of fused human arginase I for cancer therapy

2023-07-03

Abstract excerpt

Recombinant human arginase I (rhArg I) have emerged as a potential candidate for the treatment of varied pathophysiological conditions ranging from arginine-auxotrophic cancer, inflammatory conditions and microbial infection.. However, rhArg I have a low circulatory half-life, leading to poor pharmacokinetic and pharmacodynamic properties, which necessitating the rapid development of modifications to circumvent th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89593043-64fc-5be4-8831-b17d2b0c6f14
DOI
10.21203/rs.3.rs-3118315/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development and characterization of fused human arginase I for cancer therapyDOI 10.21203/rs.3.rs-3118315/v1
Select a neighboring publication to make it the new centre.